Completed NA NCT00621205

Gene Expression in Obesity and Insulin Resistance

Gene Expression in Adipose Tissue of Genes Involved in Obesity, Insulin Resistance and Lipid Metabolism Before and After Weight Loss or an Intensive Exercise Period

Sponsor: Marjukka Kolehmainen

Conditions Insulin Resistance Metabolic Syndrome

Interventions Weight reduction, Resistance training, Aerobic exercise training, Control

Updated 5 times since 2017 Last updated: Apr 16, 2012 Started: Oct 31, 2003 Primary completion: Dec 31, 2004 Completion: Dec 31, 2005

A NA clinical study on Insulin Resistance and Metabolic Syndrome, this trial is completed. The trial is conducted by Marjukka Kolehmainen and has accumulated 5 data snapshots since 2003. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2003

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Marjukka Kolehmainen
University of Eastern Finland
Wageningen University

Data source: University of Eastern Finland

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kuopio, Finland